Protein kinases as targets for anti-parasitic chemotherapy
- PMID: 15023358
- DOI: 10.1016/j.bbapap.2003.11.021
Protein kinases as targets for anti-parasitic chemotherapy
Abstract
Parasitic protozoa infecting humans have a staggering impact on public health, especially in the developing world. Furthermore, several protozoan species are major pathogens of domestic animals and have a considerable impact on food production. In many instances, the parasites have developed resistance against available chemotherapeutic agents, making the search for alternative drugs a priority. In line with the current interest in protein kinases inhibitors as potential drugs against a variety of diseases, the possibility that protein kinases may represent targets for novel anti-parasitic agents is being explored. Research into parasite protein kinases has benefited greatly from genome and EST sequencing projects, with the genomes of a few species fully sequenced (notably that of the human malaria parasite Plasmodium falciparum) and several more under way. The overall picture that emerged from research in this area shows that the phylogenetic isolation of parasitic protozoa is reflected by atypical structural and functional properties of many of their protein kinase homologues. Likewise, evidence is emerging, which suggests that the organisation of some otherwise well-conserved signal transduction pathways is divergent in some parasitic species. The differences between protein kinases of a parasite and their homologues in its host cell suggest that specific inhibition of the former can be achieved. The development of anti-parasitic drugs based on protein kinase inhibition is being pursued following two avenues: one consists of screening chemical libraries on recombinant enzymes; several protein kinases from parasitic protozoa are now available for this approach. The second approach relies on the identification of the molecular targets of kinase inhibitors which display anti-parasitic properties. This has led to promising developments in a few instances, in particular regarding PKG as a drug target against Eimeria and Toxoplasma, and purvalanol B, a purine-based CDK inhibitor which appears to affect unexpected targets in several protozoan parasites. The recent resolution of the structure of a Plasmodium protein kinase complexed with small inhibitory molecules opens the way to a rational approach towards the design of anti-parasitic drugs based on kinase inhibition.
Similar articles
-
Protein kinases as targets for antiparasitic chemotherapy drugs.Curr Drug Targets. 2007 Mar;8(3):389-98. doi: 10.2174/138945007780058979. Curr Drug Targets. 2007. PMID: 17348832 Review.
-
The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation.Prog Cell Cycle Res. 2003;5:91-101. Prog Cell Cycle Res. 2003. PMID: 14593704 Review.
-
Protein kinases as drug targets in parasitic protozoa.Trends Parasitol. 2002 Aug;18(8):366-71. doi: 10.1016/s1471-4922(02)02321-8. Trends Parasitol. 2002. PMID: 12377287 Review.
-
Antiparasitic chemotherapy: tinkering with the purine salvage pathway.Adv Exp Med Biol. 2008;625:116-32. doi: 10.1007/978-0-387-77570-8_10. Adv Exp Med Biol. 2008. PMID: 18365663 Review.
-
Inhibitors of the Purine Salvage Pathway: A Valuable Approach for Antiprotozoal Chemotherapy?Curr Med Chem. 2010;17(23):2456-81. doi: 10.2174/092986710791556023. Curr Med Chem. 2010. PMID: 20491648 Review.
Cited by
-
Structural and evolutionary adaptation of rhoptry kinases and pseudokinases, a family of coccidian virulence factors.BMC Evol Biol. 2013 Jun 6;13:117. doi: 10.1186/1471-2148-13-117. BMC Evol Biol. 2013. PMID: 23742205 Free PMC article.
-
Phosphorylated and Nonphosphorylated PfMAP2 Are Localized in the Nucleus, Dependent on the Stage of Plasmodium falciparum Asexual Maturation.Biomed Res Int. 2016;2016:1645097. doi: 10.1155/2016/1645097. Epub 2016 Jul 25. Biomed Res Int. 2016. PMID: 27525262 Free PMC article.
-
A new Apicomplexa-specific protein kinase family: multiple members in Plasmodium falciparum, all with an export signature.BMC Genomics. 2005 Mar 7;6:30. doi: 10.1186/1471-2164-6-30. BMC Genomics. 2005. PMID: 15752424 Free PMC article.
-
ROP18 is a rhoptry kinase controlling the intracellular proliferation of Toxoplasma gondii.PLoS Pathog. 2007 Feb;3(2):e14. doi: 10.1371/journal.ppat.0030014. PLoS Pathog. 2007. PMID: 17305424 Free PMC article.
-
Using existing drugs as leads for broad spectrum anthelmintics targeting protein kinases.PLoS Pathog. 2013 Feb;9(2):e1003149. doi: 10.1371/journal.ppat.1003149. Epub 2013 Feb 14. PLoS Pathog. 2013. PMID: 23459584 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials